Clinical trial
Effects of Intermittent Fasting and Exercise on Inflammation, Metabolism, and the Microbiome in Metabolic Syndrome
Recruiting now · Not applicable · 1 countries · Registry ID NCT06885255
What this study is about
The goal of this intervention trial is to assess the effects of intermittent fasting, both alone and in combination with high-intensity interval training, on patients with obesity and metabolic syndrome. The main question it aims to answer is: Does intermittent fasting, with or without high-intensity interval training, reduce chronic inflammation in patients with obesity and metabolic syndrome? Participants will follow an intermittent fasting regime for 3 months, with one intervention group additionally participating in high-intensity interval training twice a week. In addition, there are two control groups: one consisting of participants with metabolic syndrome and one consisting of generally healthy individuals. The study includes a 3-month intervention phase followed by a 3-month follow-up phase. During the 6-month study period, all participants will attend 6 in-house study visits and 2 phone visits, during which they will undergo assessments and receive nutritional counseling.
Basic eligibility
Full registry criteria
Treatments and study arms
Alternate day fasting
Participants are instructed to alternate between consuming 100% of their usual energy intake on one day and only 25% on the following day.
Time restricted eating
Subjects are instructed to limit their energy intake to 8 hours a day and to fast for the remaining 16 hours.
High-intensity interval training
Patients participate in high-intensity interval training.
Primary outcomes
High sensitivity C-reactive protein in mg/l.
Study locations
1 locations were listed when this page was built. The first 40 are shown.